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OBJECTIVES The study investigated whether b-adrenoceptor antagonists augment the hypertrophic
response of cardiomyocytes evoked by norepinephrine.
BACKGROUND In adult ventricular cardiomyocytes, stimulation of a- but not b-adrenoceptors induces
myocardial hypertrophy. Natural catecholamines, like norepinephrine, stimulate simulta-
neously a- and b-adrenoceptors. We investigated whether b-adrenoceptor stimulation
interferes with the hypertrophic response caused by a-adrenoceptor stimulation.
METHODS Adult ventricular cardiomyocytes isolated from rats were used as an experimental model.
Hypertrophic parameters under investigation were stimulation of phenylalanine incorporation
and protein mass, stimulation of 14C-uridine incorporation and RNA mass, and increases in
cell shape.
RESULTS Norepinephrine (0.01 to 10 mmol/liter) increased concentration-dependent phenylalanine
incorporation; pEC50 value was 5.9 6 0.1 (n 5 8). The a1-adrenoceptor antagonist prazosin
(0.1 mmol/liter) suppressed norepinephrine-induced increase in rate of protein synthesis.
Conversely, propranolol (1 mmol/liter) and the b1-adrenoceptor selective antagonists CPG
20712A (300 nmol/liter) or atenolol (1 mmol/liter) augmented increases in phenylalanine
incorporation caused by norepinephrine. Addition of the b2-adrenoceptor antagonist ICI
118,551 (55 nmol/liter) did not influence the hypertrophic effect of norepinephrine. Atenolol
augmented the norepinephrine-induced increases of all hypertrophic parameters investigated
(i.e., protein mass, uridine incorporation, RNA mass, cell volume, and cross-sectional area).
In the presence of norepinephrine, inhibition of b1-adrenoceptors increased the amount of
protein kinase C-a and -d isoforms translocated into the particulate fraction. The effect of
pharmacological inhibition of b1-adrenoceptors could be mimicked by Rp-cAMPS
(adenosine-39, 59-cyclic phosphorothiolate-Rp). The inhibitory effect of b1-adrenoceptor
stimulation on the a-adrenoceptor-mediated effect persisted in cardiomyocytes isolated from
hypertrophic hearts of rats submitted to aortic banding.
CONCLUSIONS In isolated ventricular cardiomyocytes from rats, b1-adrenoceptor stimulation attenuates the
hypertrophic response evoked by a1-adrenoceptor stimulation. (J Am Coll Cardiol 2001;37:
300–7) © 2001 by the American College of Cardiology
Increased plasma levels of catecholamines are commonly
found under conditions leading to myocardial hypertrophy
(1,2). Selective stimulation of a1-adrenoceptors, but not of
b-adrenoceptors, increases cellular synthesis of protein and
RNA in adult ventricular cardiomyocytes, which represent
hallmarks of myocardial hypertrophy (3–5). Natural cat-
echolamines stimulate both a1- and b1-adrenoceptors on
ventricular cardiomyocytes. It is as yet unknown whether, in
adult ventricular cardiomyocytes under simultaneous stim-
ulation of a1- and b-adrenoceptors, the b-adrenoceptor
stimulation can modulate the hypertrophic response to
a1-adrenoceptor stimulation. This question was addressed
in the study presented here.
A well-defined experimental model of cultured adult
ventricular cardiomyocytes from rats was used (4). Ventric-
ular cardiomyocytes from adult rats have previously been
shown to possess functionally coupled b1-adrenoceptors (6);
whether or not they also contain (few) b2-adrenoceptors is
still a matter of debate (6,7). They also express functional
a1-adrenoceptors but not a2-adrenoceptors (8).
Four series of experiments were performed. In the first
series, the natural catecholamine norepinephrine, the main
transmitter of the sympathetic nervous system, was used.
Norepinephrine has a high affinity for a1- and b1- but not
b2-adrenoceptors. It was tested if its effect on phenylalanine
incorporation can be modified i) by presence of the
b-adrenoceptor antagonist propranolol, ii) by the presence
of the b2-adrenoceptor antagonists CPG 20712A or ateno-
lol, or iii) by the presence of the b2-adrenoceptor antagonist
ICI 118,551. In the second series of experiments, the effect
of atenolol on the hypertrophic effect of norepinephrine was
compared to the response of selective a1-adrenoceptor
stimulation by phenylephrine. In addition to phenylalanine
incorporation, effects on protein and RNA mass and cell
volume were determined. In the third series of experiments,
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selective a1-adrenoceptor stimulation by phenylephrine was
combined with stimulation of b-adrenoceptors or addition
of dibutyryl-cyclo-AMP, to mimic b-adrenoceptor stimu-
lation. In the fourth series of experiments, some of the
experiments of the first series were repeated on cardiomy-
ocytes isolated from hypertrophic myocardium of rats sub-
mitted to aortic banding.
METHODS
Falcon tissue culture dishes were obtained from Becton-
Dickinson (Heidelberg, Germany). Boehringer Mannheim
(Mannheim, Germany) was the source for glutamine-free
medium 199 and fetal calf serum (FCS). Cytsosine-b-D-
arabinofuranoside, L-carnitine, creatine, taurine,
l-phenylephrine hydrochloride, dl-isoproterenol hydrochlo-
ride, phorbol 12-myristate 13-acetate, procaterol, atenolol,
and dibutyryl-cyclo-AMP were obtained from Sigma (De-
isenhofen, Germany). l-Norepinephrine bitartrate was pur-
chased from Serva (Heidelberg, Germany). The ICI
118,551 hydrochloride and CPG 20712A methasulfonate
were obtained from RBI/Sigma (Deisenhofen, Germany).
All other chemicals were of analytical grade.
Cell culture. Ventricular heart muscle cells were isolated
from 200-g to 250-g male Wistar rats as previously de-
scribed (9,10). Isolated cells were suspended in fetal calf
serum-free culture medium and plated at a density of 1.4 3
105 elongated cells/35-mm culture dish (Falcon type 3001;
14C-phenylalanine experiments) or 1.6 3 104 elongated
cells/22 mm culture dish (Falcon type 3815, 3H-
phenylalanine experiments). The culture dishes had been
preincubated overnight with 4% FCS in medium 199 to
allow cell attachment (9). The basic culture medium con-
sisted of medium 199 with Earle’s salts, 5 mmol/liter
creatine, 2 mmol/liter L-carnitine, 5 mmol/liter taurine, 100
IU/ml penicillin, and 100 mg/ml streptomycin. To prevent
growth of nonmyocytes, media were also supplemented with
10 mmol/liter cytosine-b-D-arabinofuranoside.
Four hours after plating, cultures were washed twice with
culture medium to remove round and nonattached cells and
supplied with FCS-free experimental media, in which cells
were incubated for a 24-h period at 37°C. The experiments
were carried out in basic culture medium (control), with
additions of norepinephrine, phenylephrine, isoprenaline,
atenolol, ICI 118,551, or dibutyrl-cyclo-AMP, at concen-
trations indicated. Ascorbic acid (100 mmol/liter) was added
to all cultures as an antioxidant.
Incorporation of phenylalanine and uridine and changes
in cellular protein and RNA mass. Incorporation of
phenylalanine into cells was determined by exposing cul-
tures to [ 3 H]pheny la lan ine (0 .5 mCi/ml) or
L-[14C]phenylalanine (0.1 mCi/ml) for 20 to 24 h (11), and
the incorporation of radioactivity into acid-insoluble cell
mass was determined as described previously (4). We
showed before that the incorporation of phenylalanine into
cell protein is linear within the first 36 h (12). Nonradio-
active phenylalanine (0.3 mmol/liter) was added to the
medium to minimize variations in the specific activity of the
precursor pool responsible for protein synthesis. Protein
contents (13) and DNA contents (14) were determined
according to previous reports. The RNA content was
determined according to an earlier study (15).
Incorporation of uridine into cells was determined as
described previously (12) by exposing cultures to
L-[14C]uridine (0.1 mCi/ml) for 6 h and the incorporation
of radioactivity into acid-insoluble cell mass was calculated.
The radioactivity was determined in the aliquots used to
quantify RNA mass as described above. We showed before
that the incorporation of 14C-uridine into RNA is linear
within the first 6 h (12).
Determination of cell volume and cross-sectional area.
Myocyte growth was determined on phase-contrast micro-
graphs recorded on tape using a CCD-video camera. Cell
volumes were calculated by the following formula: Vol-
ume 5 (radius)2 * p * length, assuming a cylindrical cell
shape. Cross-sectional area was determined by the following
formula: cross-sectional area 5 (radius)2*p.
Aortic banding. Aortic banding was performed in four
week-old male Wistar-Kyoto rats exactly as recently de-
scribed (16). Briefly, animals were anesthetized and the
aorta was exposed through a midline abdominal incision
distal to the coastal arch at the left side. The aorta was
constricted with a cutton threat just proximal to the renal
artery using a blunt wire (diameter 1 mm) to establish the
diameter of the ligature. Subsequently, after infusing a
solution of penicillin/streptomycin combination (Tar-
domyocel comp. III, Bayer AG, Leverkusen, Germany;
0.1 ml/kg) in the retroperitoneal cavity, the muscle layers
were closed with absorbable suture and the skin with
atraumatic silk suture. Controls were sham-operated, with-
out placing the stenosis around the aorta. Both groups of
animals were kept under the same condition and were used
for experiments eight weeks after surgical intervention—
that is, at 12 weeks of age. On the day of experiments, rats
with an aortic banding and age-matched, sham-operated
animals were anesthetized with pentobarbitone. The right
carotid artery and the femoral artery were cannulated, and
arterial pressure proximal and distal to the aortic constric-
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
EDTA 5 ethylenediaminete acid
EGTA 5 ethylene glycol-bis(b-aminoethyl ether)
N,N,N9,N9-tetraacetic acid
FCS 5 fetal calf serum
PKA 5 cyclic-AMP-dependent protein kinase
PKC 5 protein kinase C
PMA 5 phorbol myristate acetate
PMSF 5 phenylmethylsulfonyl fluoride
Rp-cAMPS 5 adenosine-39, 59-cyclic
phosphorothiolate-Rp
SDS–PAGE 5 sodium dodecyl sulfate–polyacrylamide
gel electrophoresis
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tion was measured with a pressure transducer (model W112,
Hugo Sachs Electronic KG, Freiburg, Germany). The
systolic blood pressure (carotid arterial pressure) in aortic
banding rats (169 6 13 mm Hg, n 5 10) was significantly
higher than in sham-operated animals (124 6 9 mm Hg,
n 5 10). Differences between pre- and post-stenotic blood
pressure measured in the carotid and the femoral artery were
52 6 11 mm Hg (n 5 10) in aortic banding rats and 1 6
2 mm Hg (n 5 10) in sham-operated animals.
Protein kinase C translocation. As a parameter of protein
kinase C (PKC) activation its translocation into the partic-
ular fraction was investigated. Cardiomyocytes were treated
for 5 min with norepinephrine with or without pretreatment
with atenolol. Thereafter, the cultures were washed twice
with ice-cold phosphate buffered solution (PBS), scraped off
in PBS and centrifuged for 2 min at 12,000 g. The
remaining pellet was redissolved in 100 ml of lysis buffer
(composition in mmol/liter: Tris 20, EGTA (ethylene
glycol-bis (b-amino ethyl ether) N,N,N9,N9-tetraacetic
acid) 10, EDTA 2, sucrose 200, PMSF (phenylmethyl
sulfononyl fluoride) 0.01, pH 7.4) and stored at 220°C.
Thereafter, the solution was mixed vigorously and centri-
fuged again for 1 h at 38,000 g. The remaining pellet was
used as the particular fraction, redissolved in 100 ml lysis
buffer to which Triton X-100 was added (final concentra-
tion 0.1% [v/v]). The solution was incubated again for 2 h
at 4°C. Thereafter, the solution was centrifuged again for
15 min with 12,000 g at 4°C. This supernatant was mixed
with 20 ml Laemmli buffer. The samples were heated for
5 min at 95°C and used for gel electrophoresis. The samples
were loaded on a 12.5% SDS-PAGE (sodium dodecyl
sulfate-polyacrylamide gel electrophoresis) and after electro-
phoretic separation they were transferred on an
immobilon-P membrane (Millipore, Bedford, Massachu-
setts). The bands were visualized and immunoblotted
against antibodies directed against PKC-a and PKC-d. The
intensity of the final bands was analyzed densitometrically
using Image-Quant software.
Statistics. Data are given as means 6 SEM from a differ-
ent culture preparations. Statistical comparisons were per-
formed by one-way analysis of variance (ANOVA) and use
of the Student-Newman-Keuls test for post hoc analysis
(17). Differences with p , 0.05 were regarded as statistically
significant.
RESULTS
Influence of b-adrenoceptor antagonists on phenylala-
nine incorporation in the presence of norepinephrine.
Norepinephrine (0.01 to 10 mmol/liter) caused
concentration-dependent increases in phenylalanine incor-
poration (Fig. 1). The increase at 10 mmol/liter was about
45% above control, and the pEC50-value was 5.9 6 0.1 (n 5
8). The a1-adrenoceptor antagonist prazosin (0.1 mmol/
liter) significantly suppressed norepinephrine-induced in-
crease in protein synthesis (Fig. 1A). In contrast, the
b-adrenoceptor antagonist propranolol (1 mmol/liter) sig-
nificantly enhanced norepinephrine-induced increase in rate
of protein synthesis (Fig. 1B). To study which
b-adrenoceptor subtype might be involved in this suppres-
sion of norepinephrine-induced protein synthesis, experi-
ments with the selective b1-adrenoceptor antagonist CPG
20712A (300 nmol/liter) and the selective b2-adrenoceptor
antagonist ICI 118,551 (55 nmol/liter) were performed as
shown in Figure 2. Both CPG 20712A and ICI 118,551
were used in concentrations at which they occupy less than
5% of b2-adrenoceptors or less than 10% of b1-
adrenoceptors, respectively (18). In the presence of CPG
20712A, norepinephrine-induced phenylalanine incorpora-
tion was significantly enhanced, whereas ICI 118,551 did
not affect it. Similar to CGP 20712A, the selective b1-
adrenoceptor antagonist atenolol (1 mmol/liter) significantly
augmented norepinephrine-induced increase in phenylala-
nine incorporation (Fig. 3).
Influence of atenolol on the hypertrophic responses
caused by norepinephrine. The effects of phenylephrine (10
mmol/liter), norepinephrine (1 mmol/liter), or norepinephrine
plus atenolol (1 mmol/liter) were compared in the next exper-
Figure 1. Incorporation of 3H-phenylalanine (Phe) of cardiomyocytes
cultured for 20 h in the presence of norepinephrine (NOR) at concentra-
tions indicated (open bars) and (A) in the presence of prazosin (0.1
mmol/liter; filled bars) or (B) propranolol (1 mmol/liter; filled bars). Data
are expressed as percentages relative to the control values. Data are
means 6 SEM from n 5 8 cultures. * 5 p , 0.05 vs. each other; ** 5 p ,
0.01 vs. each other; n.d. 5 not determined.
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imental series. Phenylephrine increased phenylalanine incor-
poration by 34%. Norepinephrine increased it by 22% in the
absence and by 42% in the presence of atenolol (Fig. 4). The
24-h change in cellular protein mass, measured as protein/
DNA ratio, was also determined (Fig. 4). Phenylephrine
increased protein mass by 27%; norepinephrine alone had no
significant effect. When norepinephrine was applied in the
presence of atenolol, it caused an increase in protein mass
(20%) comparable to that with phenylephrine.
The RNA synthesis in cardiomyocytes was estimated by
determination of the 6-h incorporation of uridine into RNA
(Fig. 5). In the presence of phenylephrine (10 mmol/liter),
uridine incorporation was increased by 25%, and in the
presence of norepinephrine (1 mmol/liter) by only 13%.
When norepinephrine was administered in the presence of
atenolol (1 mmol/liter), the increment in uridine incorpo-
ration became comparable to that seen in presence of
phenylephrine. Similar changes were seen when the 24-h
increase in total RNA mass, determined as RNA/DNA
ratio, was measured (Fig. 5). Phenylephrine increased RNA
mass by 13%, norepinephrine by only 7%, but norepineph-
rine combined with atenolol by 13%.
The influences on cell shapes of either norepinephrine or
norepinephrine plus atenolol were also investigated. Com-
pared to untreated control cells, norepinephrine (1 mmol/
liter) increased cell volume by 6.4%; norepinephrine plus
atenolol, however, increased it by 36.1% (Table 1). Cross-
sectional area of the cells was increased by 16.0% compared
to untreated control cells in the presence of norepinephrine,
and by 46.0% in the presence of norepinephrine plus
atenolol.
Figure 2. Incorporation of 3H-phenylalanine (Phe) of cardiomyocytes
cultured for 20 h in the presence of norepinephrine (NOR, open bars) at
concentrations indicated, in the presence of NOR and CPG 20712A (300
nmol/liter; filled bars) or in the presence of NOR and ICI 118,551 (55
nmol/liter; hatched bars). Data are expressed as percentages relative to the
control values. Data are means 6 SEM from n 5 8 cultures. * 5 p , 0.05
vs. each other; ** 5 p , 0.01 vs. each other.
Figure 3. Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes
cultured for 24 h in the presence of norepinephrine (NOR) at concentra-
tions indicated (open bars) or NOR and atenolol (1 mmol/liter; filled
bars). Data are expressed as percentages relative to the control values. Data
are means 6 SEM from n 5 6 cultures. * 5 p , 0.05 vs. each other.
Figure 4. Incorporation of 14C-phenylalanine (Phe) and protein mass
(protein/DNA ratio) of cardiomyocytes cultured for 24 h in presence of
phenylephrine (PE, 10 mmol/liter), norepinephrine (NOR, 1 mmol/liter),
or NOR and atenolol (ATE, 1 mmol/liter). Data are expressed as
percentages relative to the control values. Data are means 6 SEM from
n 5 6 cultures. * 5 p , 0.05 vs. control; # 5 p , 0.05 vs. NOR. Open bars
5 PE; filled bars 5 NOR; hatched bars 5 ATE 1 NOR.
Figure 5. Incorporation of 14C-uridine (Uri) and RNA mass (RNA/DNA
ratio) of cardiomyocytes cultured in presence of phenylephrine (PE, 10
mmol/liter), norepinephrine (NOR, 1 mmol/liter), or NOR and atenolol
(ATE, 1 mmol/liter). Cells were incubated with the agonists for 6 h in case
of RNA synthesis and 24 h in case of RNA mass. Data are expressed as
percentages relative to the control values. Data are means 6 SEM from
n 5 6 cultures. * 5 p , 0.05 vs. C; # 5 p , 0.05 vs. NOR. Open bars 5
PE; filled bars 5 NOR; hatched bars 5 ATE 1 NOR.
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Intracellular signaling involved in the b1-/a-adrenoceptor
cross-talk. The third series of experiments investigated
whether b1-adrenoceptor stimulation influences the early
events in a-adrenoceptor-mediated hypertrophy. As illus-
trated in Figure 6A, atenolol augmented the
norepinephrine-induced translocation of PKC-a and -d
isoforms into the particulate fraction. The hypertrophic
effects evoked by the selective a-adrenoceptor agonist phen-
ylephrine (10 mmol/liter) were significantly reduced by
b1-adrenoceptor stimulation (isoprenaline plus ICI
118,551) (Fig. 6B). In contrast, selective stimulation of
b1-adrenoceptors did not antagonize the hypertrophic re-
sponse evoked by direct stimulation of PKC—that is, by
addition of phorbol myristate acetate (PMA, 100 nmol/
liter) (Fig. 6B). Therefore, we conclude that stimulation of
b1-adrenoceptors attenuates the activation of PKC caused
by a-adrenoceptor stimulation.
The inhibitory effect of b-adrenoceptor stimulation on
the initiation of protein synthesis was also studied in
another set of experiments in which endothelin-1 (10
nmol/liter) was used to stimulate protein synthesis. These
experiments were performed to investigate whether the
inhibitory effect of b-adrenoceptor stimulation on protein
synthesis can also be demonstrated for other agonists that
stimulate protein synthesis via PKC activation. The hyper-
trophic effect evoked by endothelin (increase in phenylala-
nine incorporation to 119 6 5%, p , 0.01 vs. control, n 5
7) was blunted in co-presence of isoprenaline (93 6 6%, p ,
0.01 vs. endothelin alone, n 5 7).
It was further investigated whether this inhibitory effect of
b1-adrenoceptor stimulation is cAMP (cyclic adenosine
monophosphate) dependent. Therefore, we performed exper-
iments in which the b1-adrenoceptor-mediated inhibitory
effect was antagonized on the postreceptor level by addition of
Rp-cAMPS (adenosine-39, 59-cyclic phosphorothiolate-Rp),
which augmented the hypertrophic response caused by norepi-
nephrine. At 1 mmol/liter, norepinephrine did not affect
protein synthesis. However, in co-presence of Rp-cAMPS
phenylalanine incorporation was increased by 42% (Fig. 7). In
addition, Rp-cAMPS also augmented the hypertrophic re-
sponse evoked by phenylephrine in the presence of isoprenaline
and ICI 118,551. In the presence of isoprenaline and ICI
118,551, phenylalanine increased protein synthesis by only 4%,
but in co-presence of Rp-cAMPS this response was aug-
mented to 38% (Fig. 7). Finally, the hypertrophic effect evoked
by phenylephrine was markedly reduced by addition of
dibutyrl-cyclic AMP (Fig. 7).
Influence of b-adrenoceptor antagonists on phenylala-
nine incorporation in the presence of norepinephrine in
hypertrophied cardiomyocytes. In a last set of experi-
ments, it was investigated whether the inhibitory effect of
b1-adrenoceptor stimulation on the a-adrenoceptor-
Table 1. Influence of Atenolol on Cell Shape Alterations
Caused by Norepinephrine
Cell Volume
Cross-sectional
Area
Control 233.3 6 5.5 mm3 10.0 6 0.2 mm2
Norepinephrine 248.3 6 5.8 mm3* 11.6 6 0.3 mm2*
(16.4%) (116.0%)
Norepinephrine 1
Atenolol
317.5 6 9.2 mm3*# 14.7 6 0.4 mm2*#
(136.1%) (147.0%)
Cardiomyocytes were incubated for 24 h, and thereafter their picture was recorded on
a videotape, from which both cell volume and cross-sectional area were calculated.
Cells from untreated control cultures, from cultures treated with norepinephrine
(1 mmol/liter), or norepinephrine 1 atenolol (1 mmol/liter) were analyzed. Data
represent means 6 SEM from 87 to 107 cells. *p , 0.05 vs. control; #p , 0.05 vs.
norepinephrine alone.
Figure 6. (A) Western blots indicating the translocation of protein kinase
C (PKC) isoforms a and d into the particular fraction. Cells were
incubated for 5 min (control, C), with norepinephrine (NOR, 1 mmol/
liter) or norepinephrine and atenolol (NOR 1 Ate, 1 mmol/liter). (B)
Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes cultured for
24 h in presence of phenylephrine (PE, 10 mmol/liter), phorbol myristate
acetate (PMA, 0.1 mmol/liter), or PE and PMA in co-presence of
isoprenaline (1 mmol/liter) and ICI 118,551 (ICI, 0.1 mmol/liter) (ISO 1
ICI). Data are expressed as percentages relative to the control values. Data
are means 6 SEM from n 5 6 cultures. * 5 p , 0.05 vs. each other.
Figure 7. Incorporation of 14C-phenylalanine (Phe) of cardiomyocytes
cultured for 24 h in presence of norepinephrine (NOR, 1 mmol/liter),
phenylephrine (PE, 10 mmol/liter), or PE in co-presence of isoprenaline (1
mmol/liter) and ICI 118,551 (ICI, 0.1 mmol/liter) (ISO 1 ICI). Where
indicated Rp-cAMPS (RpcAMPS, 10 mmol/liter) or dibutyryl-cAMP
(dbcAMP, 1 mmol/liter) was added. Data are expressed as percentages
relative to the control values. Data are means 6 SEM from n 5 6 cultures.
* 5 p , 0.05 vs. each other.
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mediated growth effect is preserved in cardiomyocytes
isolated from hearts with hypertrophy and b-adrenoceptor
desensitization. For this purpose, cardiomyocytes from rats
that had received aortic constriction for eight weeks were
isolated, and growth response to norepinephrine was inves-
tigated in the absence and presence of propranolol. Hearts
from rats that had undergone aortic banding showed in-
creased left ventricular weight compared to sham-operated
animals (Table 2A). In ventricular myocardium of these
rats, activation of left ventricular adenylyl cyclase by iso-
prenaline was significantly reduced compared to sham-
operated animals (Table 2A), indicating a desensitization of
b-adrenoceptors. Similarly, the maximal increase in force of
contraction of electrically driven left ventricular strips in-
duced by isoprenaline was significantly lower than in strips
of sham-operated animals (16). Cardiomyocytes isolated
from animals with aortic banding showed a lower
norepinephrine-induced increase in protein synthesis com-
pared to those isolated from sham-operated animals. Nev-
ertheless, presence of propranolol augmented the hypertro-
phic effect of norepinephrine in both animals with aortic
banding and sham-operated animals (Table 2B).
DISCUSSION
Main findings of this study. The central question of
this study was whether simultaneous stimulation of b-
adrenoceptors can modulate the hypertrophic response to
a1-adrenoceptor stimulation on adult ventricular cardiomy-
ocytes. The results of the present study show that b1-
adrenoceptor stimulation attenuates all investigated
hypertrophy-related effects of a1-adrenoceptor stimulation.
Phenylalanine incorporation was determined for a one-
day period. The changes described here in phenylalanine
incorporation were paralleled by similar changes in cellular
protein mass, indicating that they primarily represent
changes in protein synthesis. Analogous considerations
apply to changes in uridine incorporations that are accom-
panied by changes in RNA mass. In addition, cell volume
and cross-sectional areas of the cells also increased, indicat-
ing hypertrophic growth of the cardiomyocytes.
Intracellular signals involved in the b-adrenoceptor-
mediated inhibitory effect. In the present study, in adult
rat ventricular cardiomyocytes, b1-adrenoceptor stimulation
attenuated the hypertrophic response to a1-adrenoceptor
stimulation. This conclusion is based on the following
findings: a) The hypertrophic response to norepinephrine is
enhanced by b1-adrenoceptor blockade by CPG 20712A or
atenolol, but not affected by the highly selective b2-
adrenoceptor antagonist ICI 118,551; b) the hypertrophic
response to the a1-adrenoceptor agonist phenylephrine is
significantly inhibited by isoprenaline in the presence of ICI
118,551 acting under these conditions solely at b1-
adrenoceptors. This inhibitory effect of b1-adrenoceptor
stimulation involves the cyclic-AMP-dependent protein
kinase (PKA) system: thus, dibutyryl-cyclic-AMP can
mimic the inhibitory effects of b1-adrenoceptor stimulation
on phenylephrine-induced increase in rate of protein syn-
thesis; moreover, the PKA-inhibitor Rp-cAMPS signifi-
cantly enhanced norepinephrine-evoked increase in protein
synthesis and abolished b1-adrenoceptor-mediated inhibi-
tion of phenylephrine-induced increases in rate of protein
synthesis. Thus, taken together, in adult rat ventricular
cardiomyocytes the hypertrophic response to norepineph-
rine is composed of two components: an a1-adrenoceptor-
mediated stimulation and a b1-adrenoceptor-mediated in-
hibition. The b1-adrenoceptor-induced inhibition of
Table 2. Influence of b-Adrenoceptor Inhibition on the Hypertrophic Responsiveness to
Norepinephrine in Cardiomyocytes From Aortic Banded Rats
A: Characteristics of sham-operated animals and those with aortic banding
LV/BW
(mg/g)
ISO-Stimulated Force
(Increment mN)
ISO-Stimulated
Adenylate Cylcase
(pmol/mgpmin)
Sham-operated 2.37 6 0.11 (10) 4.4 6 0.3 (6) 26.7 6 5.0 (6)
Aortic banding 3.23 6 0.18# (10) 2.4 6 0.3* (9) 14.0 6 1.4* (6)
Animals were investigated eight weeks after operation. Data are left ventricular (LV) weights normalized to body weight
(LV/BW), the increase in contractile force of left ventricular strips in the presence of isoprenaline (ISO) (10 mmol/liter), and
peak accumulation of cyclic-AMP under isoprenaline. Data for ISO-induced increase in force of contraction were from Kotchi
et al. (16).
*p , 0.05 vs. sham-operated.
B: Phenylalanine incorporation in isolated cardiomyocytes isolated from sham-operated animals and
those with aortic banding in the presence of norepinephrine (Nor) or norepinephrine and propranolol
(Nor 1 Propranolol)
Nor Nor 1 Propranolol
Sham-operated (6) 143 6 3 -*- 158 6 4
Aortic banding (9) 129 6 3 -*- 141 6 8
Cardiomyocytes were isolated from sham-operated animals or those with aortic banding. Phenylalanine incorporation was
determined in the presence of norepinephrine (10 mmol/liter) in the absence or presence of propranolol (1 mmol/liter). Data
represent % of unstimulated control values.
*p , 0.05.
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protein synthesis is mediated by the cAMP/PKA activation
pathway.
Additional experiments revealed that norepinephrine-
evoked translocation of PKC (i.e., activation of PKC) was
markedly enhanced by atenolol; thus, in rat cardiomyocytes
b1-adrenoceptor stimulation attenuated activation of PKC,
which is known to be an essential step in a1-adrenoceptor-
mediated hypertrophic response (19). Conversely, when
PKC was activated receptor-independently by the phorbo-
lester PMA, b1-adrenoceptor stimulation failed to affect
PKC translocation. This indicates that the interaction
between a1- and b1-adrenoceptor signaling pathways occur
at or above the level of PKC activation.
Comparison with other in vitro systems. Our results are
in apparent contrast to studies on adult ventricular cardio-
myocytes isolated from rabbits (5) or neonatal cardiomyo-
cytes from rats (20) in which inhibition of b-adrenoceptors
was found to reduce the increase in protein synthesis caused
by norepinephrine. In those types of studies, however,
cardiomyocytes were cultured under specific conditions in
which the sole stimulation of b-adrenoceptors provokes a
cellular hypertrophic effect of its own. Such a direct growth-
promoting effect of b-adrenoceptor stimulation is not nor-
mally present in adult ventricular cardiomyocytes from rat
that were used in the present study (4). It can appear when
cells are cultured for prolonged time under specific culture
conditions (12,21)—for example, in the presence of FCS.
Our results demonstrate, however, that under basal condi-
tions (e.g., without precultivation of cardiomyocytes with
various agonists) the hypertrophic response caused by nor-
epinephrine is reduced by simultaneous stimulation of
b1-adrenoceptors.
In vivo relevance of the observed b-adrenoceptor-
mediated effect. The pathophysiological relevance of this
cross-talk between a1- and b1-adrenergic receptor stimulation
in the hypertrophic response to norepinephrine in adult cardi-
omyocytes is at present only partly understood. There is no
doubt that a1-adrenoceptor stimulation causes increases in the
rate of protein synthesis. The b1-adrenoceptor stimulation can
inhibit the hypertrophic response induced by norepinephrine
(this study). Our experiments on rats with myocardial hyper-
trophy but not heart failure indicate that the b1-adrenergic
attenuation of the a1-adrenergic growth effect is still active in
compensated hypertrophy. In such a situation one should
therefore expect an increase of hypertrophic growth upon use
of b1-adrenoceptor blockers. It has indeed been reported that
patients with moderate hypertension, but without cardiac
failure, develop more cardiac hypertrophy when receiving
atenolol, independent from its blood-pressure-lowering effect
(22). The described mechanism may also explain why, in
general, in experimental models associated with high blood
pressure, atenolol was found less effective to initiate regression
of hypertrophy as opposed to, e.g., angiotensin-converting
enzyme (ACE) inhibitors (23).
Conclusions. Finally, b1-adrenoceptor stimulation can
also induce cardiac myocyte apoptosis, and, by this, contrib-
ute to myocardial failure (24). In severe heart failure,
b1-adrenoceptor-blocker might prevent cardiac myocyte
apoptosis, and this might contribute to the beneficial effects
in patients with chronic heart failure (reviewed in Bristow,
25). Moreover, under these conditions b-blockers might
resensitize the desensitized b1-adrenoceptors in chronic
heart failure (reviewed in Brodde et al., 26), thus improving
the inhibitory effects of b1-adrenoceptor stimulation on the
a1-adrenoceptor-mediated hypertrophic response. Hence,
the influence of b1-adrenoceptor blockers on the extent of
myocardial hypertrophy and heart failure might depend on
the clinical situation.
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